Year |
Citation |
Score |
2022 |
Guarracino DA, Iannaccone J, Cabrera A, Kancharla S. Harnessing the Therapeutic Potential and Biological Activity of Antiviral Peptides. Chembiochem : a European Journal of Chemical Biology. e202200415. PMID 36075015 DOI: 10.1002/cbic.202200415 |
0.624 |
|
2017 |
Guarracino DA, Oldfield A, Gentile K, Martin S, Nguyen D, Barreto G, Kouba C. Head-to-Tail Cyclic Peptide Inhibitors of the Interaction between human von Willebrand Factor and Collagen. Chemmedchem. PMID 29059501 DOI: 10.1002/cmdc.201700522 |
0.521 |
|
2017 |
Guarracino DA, Gentile K, Grossman A, Li E, Refai N, Mohnot J, King D. Salt-bridging effects on short amphiphilic helical structure and introducing sequence-based short beta-turn motifs. Journal of Biomolecular Structure & Dynamics. 1-11. PMID 28278764 DOI: 10.1080/07391102.2017.1286265 |
0.592 |
|
2015 |
Guarracino DA, Alabanza AM, Robertson CT, Sanghvi SS. The role of primary sequence in helical control compared across short α- and β(3)-peptides. Journal of Biomolecular Structure & Dynamics. 33: 597-605. PMID 24625290 DOI: 10.1080/07391102.2014.897260 |
0.531 |
|
2015 |
Guarracino DA. Wheel of fortune – cyclic peptides hit the mimetic jackpot: Current syntheses, uses and roles for cyclic peptide mimetics Current Chemical Biology. 9: 36-52. |
0.626 |
|
2014 |
Lao BB, Drew K, Guarracino DA, Brewer TF, Heindel DW, Bonneau R, Arora PS. Rational design of topographical helix mimics as potent inhibitors of protein-protein interactions. Journal of the American Chemical Society. 136: 7877-88. PMID 24972345 DOI: 10.1021/Ja502310R |
0.404 |
|
2013 |
Ferrie JJ, Gruskos JJ, Goldwaser AL, Decker ME, Guarracino DA. A comparative protease stability study of synthetic macrocyclic peptides that mimic two endocrine hormones. Bioorganic & Medicinal Chemistry Letters. 23: 989-95. PMID 23312470 DOI: 10.1016/j.bmcl.2012.12.041 |
0.625 |
|
2011 |
Guarracino DA, Bullock BN, Arora PS. Mini review: protein-protein interactions in transcription: a fertile ground for helix mimetics. Biopolymers. 95: 1-7. PMID 20882600 DOI: 10.1002/Bip.21546 |
0.335 |
|
2009 |
Guarracino DA, Arora PS. Making strides in peptide-based therapeutics. Chemistry & Biology. 16: 919-20. PMID 19778718 DOI: 10.1016/J.Chembiol.2009.09.005 |
0.536 |
|
2009 |
Harker EA, Daniels DS, Guarracino DA, Schepartz A. Beta-peptides with improved affinity for hDM2 and hDMX. Bioorganic & Medicinal Chemistry. 17: 2038-46. PMID 19211253 DOI: 10.1016/J.Bmc.2009.01.039 |
0.452 |
|
2006 |
Guarracino DA, Chiang HR, Banks TN, Lear JD, Hodsdon ME, Schepartz A. Relationship between salt-bridge identity and 14-helix stability of beta3-peptides in aqueous buffer. Organic Letters. 8: 807-10. PMID 16494446 DOI: 10.1021/Ol0527532 |
0.71 |
|
2005 |
Kritzer JA, Stephens OM, Guarracino DA, Reznik SK, Schepartz A. beta-Peptides as inhibitors of protein-protein interactions. Bioorganic & Medicinal Chemistry. 13: 11-6. PMID 15582447 DOI: 10.1016/J.Bmc.2004.09.009 |
0.698 |
|
2005 |
Kritzer JA, Stephens OM, Guarracino DA, Reznik SK, Schepartz A. ?-Peptides as Inhibitors of Protein?Protein Interactions Cheminform. 36. DOI: 10.1002/chin.200513287 |
0.707 |
|
Show low-probability matches. |